CombiMatrix (CBMX) Reports Q3 Loss of $0.23

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PCVX
2. NVDA
3. EVTL
4. ATH
5. SPY
6. KLC
7. CME
8. USO
9. AMD
10. WFC

Go back to CombiMatrix (CBMX) Reports Q3 Loss of $0.23

CombiMatrix Reports Third Quarter 2014 Financial and Operating Results

November 4, 2014 4:05 PM EST

Reports Record Revenue, Cash Reimbursement and Test Volumes

Company to Host Conference Call and Webcast Today at 1:30 p.m. PST

IRVINE, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq: CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental disorders, today reported financial results for the third quarter and nine months ended September 30, 2014. The Company will host a conference call and webcast at 1:30 p.m. PST, today.

"We continued to execute on our... More